STAEFA, SWITZERLAND – Sonova Holding AG announced its financial results for the fiscal year 2024/25, reporting growth across all four business segments and confirming a planned CEO transition. The company saw full-year sales of CHF 3.87 billion (~$4.26 billion USD), marking a 7.6% increase in local currencies and a 6.6% rise in Swiss francs.
Adjusted EBITA grew 7.4% in local currencies to CHF 807.8 million (USD 891 million), with margin improvements driven by new product launches and enhanced operational efficiency.
“We are pleased to report a solid performance overall and an accelerating momentum, achieving above-market growth across all four businesses in the second half. Growth in the Hearing Instruments segment was supported by the successful launch of the Phonak Infinio and Sphere Infinio platforms, which were well received and resulted in substantial market share gains.”
–Arnd Kaldowski, outgoing CEO of Sonova
Sales Growth Fueled by Product Innovation
Revenue growth was supported by the August 2024 launch of the Phonak Infinio and Sphere Infinio platforms, which contributed to sales gains in both the Hearing Instruments and Audiological Care segments. Despite a softening in the U.S. private hearing aid market later in the year, the Group recorded 6.4% organic growth, with acquisitions adding 1.2% to the top line.
Regionally, EMEA posted 7.0% growth in local currencies, while the U.S. saw a 7.7% increase, driven by strong hearing instrument sales. In the rest of the Americas, sales rose 10.8%, bolstered by network expansion in Audiological Care and strong performance in Canada and Brazil. The Asia-Pacific region reported 8.1% growth, led by Australia and strong cochlear implant sales in China.
Sonova’s adjusted gross profit margin increased to 72.4%, aided by higher sales volume and favorable pricing for newer product platforms. Operating costs, though elevated due to new product launches and labor inflation, were contained in the second half through cost control measures.
“Building on this sales momentum and benefiting from the measures undertaken to enhance productivity and improve our cost structure, we are entering the new financial year from a position of strength”
–Arnd Kaldowski
The Hearing Instruments segment reported CHF 3.56 billion (USD 3.92 billion) in revenue, up 7.5% in local currencies. The Cochlear Implants segment achieved CHF 303.9 million (USD 334.8 million), reflecting a 9.5% increase and continued market share gains.
Adjusted EPS rose 10.6% in local currencies to CHF 10.81 (USD 11.92), while reported EPS declined 10% due to currency effects and increased tax liabilities. Free cash flow totaled CHF 500.5 million (USD 551.9 million).
Leadership Transition: Bernard to Succeed Kaldowski
Eric Bernard, former WSA CEO will become the new CEO of Sonova
Sonova also announced that Arnd Kaldowski will step down as CEO on September 30, 2025, citing personal reasons. Eric Bernard, former CEO of WS Audiology and a veteran executive in both the hearing and optical industries, will join Sonova on July 1 and assume full responsibilities as CEO by October 1, 2025.
“Sonova is in an even stronger position today than it was eight years ago,” said Robert Spoerry, Chair of the Board. “Under Arnd’s successful leadership, we have seen Sonova grow its market share and continue to introduce impactful innovation in the field of hearing aids, including the groundbreaking real-time AI powered Sphere Infinio hearing aids.”
Bernard brings over 30 years of global leadership experience, including five years at WS Audiology, where he oversaw the merger of Widex and Sivantos. He also served for 25 years at Essilor, where he held various executive roles.
“I am very pleased to welcome Eric Bernard as the new CEO of Sonova. Eric’s extensive global leadership experience and management skills in the hearing care and adjacent industries are essential as we continue to advance Sonova’s vision.”
–Robert Spoerry
Sonova has maintained its outlook for the 2025/26 financial year, projecting 5–9% sales growth and 14–18% EBITA growth at constant exchange rates. However, the company anticipates currency effects will reduce reported Swiss franc growth by approximately 4–6 percentage points.
About Sonova
Sonova is a global leader in innovative hearing care solutions: from personal audio devices and wireless communication systems to audiological care services, hearing aids and cochlear implants. The Group was founded in 1947 and is headquartered in Stäfa, Switzerland.
Sonova operates through four businesses – Hearing Instruments, Audiological Care, Consumer Hearing and Cochlear Implants – and the core brands Phonak, Unitron, AudioNova, Sennheiser (under license) and Advanced Bionics as well as recognized regional brands. The Group’s globally diversified sales and distribution channels serve an ever growing consumer base in more than 100 countries.
In the 2023/24 financial year, the Group generated sales of CHF 3.6 billion, with a net profit of CHF 610 million. Over 18,000 employees are working on achieving Sonova’s vision of a world where everyone enjoys the delight of hearing.
Source: Sonova
